Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Ranolazine

Ranolazine

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Ranolazine

32 trials tracked of Ranolazine: 19 in phase 3 or 4.

32Trials tracked
19Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 11 Phase 3 8 Phase 2 8 Phase 1 2 Other / NA 3
  1. Phase 4 Impact of Ranolazine in Blood Markers in Women With Angina and Metabolic Syndrome Completed
  2. Phase 4 Study of Ranolazine in the Treatment of Pulmonary Hypertension Associated With Diastolic Left Ventricular Dysfunction Completed
  3. Phase 4 Ranolazine and Microvascular Angina by PET in the Emergency Department Completed
  4. Phase 4 An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041) Completed
  5. Phase 4 Effects of Ranolazine and Exercise on Daily Physical Activity Trial Completed
  6. Phase 4 Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina Completed
Show 26 more trials
  1. Phase 4 Targeting Right Ventricle in Pulmonary Hypertension Gilead Completed
  2. Phase 4 Pharmacokinetics of Single-Dose Oral Ranolazine in Hemodialysis Patients Completed
  3. Phase 4 Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging Completed
  4. Phase 4 Ranolazine for the Treatment of Chest Pain in HCM Patients Completed
  5. Phase 4 Targeting the Right Ventricle in Pulmonary Hypertension Completed
  6. Phase 3 Ranolazine for Incomplete Vessel Revascularization Post-Percutaneous Coronary Intervention (PCI) Completed
  7. Phase 3 Ranolazine When Added to Glimepiride in Subjects With Type 2 Diabetes Mellitus Completed
  8. Phase 3 Reduction of Ischemic Myocardium With Ranolazine-Treatment in Patients With Acute Myocardial Ischemia Completed
  9. Phase 3 Ranolazine and Pulmonary Hypertension Completed
  10. Phase 3 Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus Completed
  11. Phase 3 Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD Completed
  12. Phase 3 Ranolazine Implantable Cardioverter-Defibrillator Trial Completed
  13. Phase 3 A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone Completed
  14. Phase 2 Ranolazine Among Unrevascularized Chronic Stable Angina Patients Completed
  15. Phase 2 Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA) Completed
  16. Phase 2 Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation Completed
  17. Phase 2 Exploratory Study to Access the Metabolic Effects of Ranolazine in Subjects With Type 2 Diabetes Mellitus When Added to Ongoing Non-insulin Antidiabetic Therapy Completed
  18. Phase 2 Ranolazine Mediated PVC Reduction in Ischemic Heart Disease Completed
  19. Phase 2 Microvascular Coronary Disease In Women: Impact Of Ranolazine Completed
  20. Phase 2 Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion Completed
  21. Phase 2 Long-term Efficacy Study of Sodium Channel Blocker in LQT3 Patients Completed
  22. Phase 1 CiPA Phase 1 ECG Biomarker Validation Study Completed
  23. Phase 1 Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects Completed
  24. N/A The Effects of Ranolazine on Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction Completed
  25. N/A Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia Completed
  26. N/A A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine Completed

Showing the 32 most-cited and recently-updated of 32 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.